EMA opens review of China’s Sinovac coronavirus jab

The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market.

The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market.

The EMA’s human medicines committee’s “decision to start the rolling review is based on preliminary results from laboratory studies (non-clinical data) and clinical studies,” the Amsterdam-based agency said. jhe/wdb

LEAVE A REPLY

Please enter your comment!
Please enter your name here